These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8622703)
21. A coiled-coil tetramerization domain of BCR-ABL is essential for the interactions of SH2-containing signal transduction molecules. Tauchi T; Miyazawa K; Feng GS; Broxmeyer HE; Toyama K J Biol Chem; 1997 Jan; 272(2):1389-94. PubMed ID: 8995449 [TBL] [Abstract][Full Text] [Related]
22. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products. Allen PB; Morgan GJ; Wiedemann LM Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169 [TBL] [Abstract][Full Text] [Related]
23. Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects. Perazzona B; Lin H; Sun T; Wang Y; Arlinghaus R Oncogene; 2008 Apr; 27(15):2208-14. PubMed ID: 17934518 [TBL] [Abstract][Full Text] [Related]
24. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Muller AJ; Young JC; Pendergast AM; Pondel M; Landau NR; Littman DR; Witte ON Mol Cell Biol; 1991 Apr; 11(4):1785-92. PubMed ID: 2005881 [TBL] [Abstract][Full Text] [Related]
25. The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Maru Y; Witte ON Cell; 1991 Nov; 67(3):459-68. PubMed ID: 1657398 [TBL] [Abstract][Full Text] [Related]
27. Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death. Wang Y; Liu J; Wu Y; Luo W; Lin SH; Lin H; Hawk N; Sun T; Guo JQ; Estrov Z; Talpaz M; Champlin R; Arlinghaus RB Cancer Res; 2001 Jan; 61(1):138-44. PubMed ID: 11196151 [TBL] [Abstract][Full Text] [Related]
28. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl. Lionberger JM; Smithgall TE Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130 [TBL] [Abstract][Full Text] [Related]
29. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells. Campbell ML; Li W; Arlinghaus RB Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598 [TBL] [Abstract][Full Text] [Related]
30. Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl. Gaston I; Johnson KJ; Oda T; Bhat A; Reis M; Langdon W; Shen L; Deininger MW; Druker BJ Exp Hematol; 2004 Jan; 32(1):113-21. PubMed ID: 14725908 [TBL] [Abstract][Full Text] [Related]
31. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family. Reuther GW; Fu H; Cripe LD; Collier RJ; Pendergast AM Science; 1994 Oct; 266(5182):129-33. PubMed ID: 7939633 [TBL] [Abstract][Full Text] [Related]
32. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Maru Y; Peters KL; Afar DE; Shibuya M; Witte ON; Smithgall TE Mol Cell Biol; 1995 Feb; 15(2):835-42. PubMed ID: 7529874 [TBL] [Abstract][Full Text] [Related]
33. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl. He Y; Wertheim JA; Xu L; Miller JP; Karnell FG; Choi JK; Ren R; Pear WS Blood; 2002 Apr; 99(8):2957-68. PubMed ID: 11929787 [TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148). Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840 [TBL] [Abstract][Full Text] [Related]
35. The involvement of Bcr in leukemias with the Philadelphia chromosome. Arlinghaus RB Crit Rev Oncog; 1998; 9(1):1-18. PubMed ID: 9754444 [TBL] [Abstract][Full Text] [Related]
36. Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. Pendergast AM; Muller AJ; Havlik MH; Clark R; McCormick F; Witte ON Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5927-31. PubMed ID: 1712111 [TBL] [Abstract][Full Text] [Related]
37. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971 [TBL] [Abstract][Full Text] [Related]
38. KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts. Andersson BS; Collins VP; Kurzrock R; Larkin DW; Childs C; Ost A; Cork A; Trujillo JM; Freireich EJ; Siciliano MJ Leukemia; 1995 Dec; 9(12):2100-8. PubMed ID: 8609723 [TBL] [Abstract][Full Text] [Related]
39. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. McWhirter JR; Galasso DL; Wang JY Mol Cell Biol; 1993 Dec; 13(12):7587-95. PubMed ID: 8246975 [TBL] [Abstract][Full Text] [Related]
40. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase. Jain SK; Langdon WY; Varticovski L Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]